Abbott Architect News Today

This analysis uses data from 2 studies to explore whether lowering the threshold for fecal immunochemical test positivity can achieve comparable levels of

At the time of the first wave of the COVID-19 pandemic, patients with cancer were considered to be at high risk of serious illness and had a higher exposure risk since they needed frequent and nondeferrable hospital visits. Serological tests were not routinely used, and seroprevalence in this population was unknown. A single-center, cross-sectional study was developed to determine the seroprevalence of anti-SARS-CoV-2 antibodies (Abs) in patients with cancer undergoing systemic antineoplastic t...

Researchers screen kidney transplant recipients to evaluate their serological responses following immunization with three doses of the COVID-19 vaccine.

Outdoor courier lockboxes can reach high temperatures during the summer, leaving patient samples at significant risk of preanalytical error.

An assay capable of detecting SARS-CoV-2 antibodies in breast milk and other samples In a recent study by US researchers (currently available on the medRxiv* preprint server), a specific immunoassay based on the spike glycoprotein’s receptor-binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not only well suited for the detection of antibody response after infection and vaccination but may also represent a method of choice when conducting seroepidemio...

New antibody testing study finds evidence of early COVID-19 infections in the U.S. A new antibody testing study examining samples originally collected through the National Institutes of Healths All of Us Research Program found evidence of SARS-CoV-2 infections in five states earlier than had initially been reported. These findings were published in the journal Clinical Infectious Diseases. The results expand on findings from a Centers for Disease Control and Prevention study that suggested SAR...

Irfan Tramboo Srinagar, Feb 14: A Sero-Prevalence Study carried by the Government Medical College (GMC), Srinagar has stated that around 27 per cent of healthcare workers (HCWs) across Kashmir hospitals show the presence of antibodies against COVID-19. The presence of the anti-bodies, doctors said, suggests that these healthcare workers were exposed to the COVID-19 at some point of time which makes rest of the 70 per cent of the healthcare workers susceptible to the infection. The study has bee...

Read more about 27% of healthcare workers in Kashmir have antibodies: Covid sero survey on Business Standard. A sero survey conducted in various hospitals of the Kashmir Valley has found that around 27 per cent of the healthcare workers have antibodies against COVID-19.

"A sero prevalence study was conducted by Government Medical College (GMC), Srinagar among healthcare providers of the Kashmir Division in January to detect SARS-CoV-2 specific IgG antibodies," said Muhammad Salim Khan, head of community medicine at GMC.

SRINAGAR: A sero survey conducted in various hospitals of the Kashmir Valley has found that around 27 per cent of the healthcare workers have antibodies